Vertex Pharmaceuticals (VRTX) Earnings Analysis
Vertex Pharmaceuticals (VRTX) next reports earnings on 2026-08-03, consensus EPS 4.74 USD. Last quarter (2026-05-04) it beat with EPS 4.47 USD vs 4.24 USD est (+5.4%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E 27.78.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does VRTX next report earnings?
| Next earnings date | 2026-08-03 |
|---|---|
| Consensus EPS estimate | 4.74 USD |
| Revenue estimate | 3.23B |
VRTX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-04 | 4.47 USD | 4.24 USD | +5.4% | Beat |
| 2026-02-12 | 5.03 USD | 5.11 USD | -1.6% | Miss |
| 2025-11-03 | 4.8 USD | 4.57 USD | +5% | Beat |
| 2025-08-04 | 4.52 USD | 4.29 USD | +5.4% | Beat |
| 2025-05-05 | 4.06 USD | 4.25 USD | -4.5% | Miss |
| 2025-02-10 | 3.98 USD | 4.02 USD | -1% | Miss |
| 2024-11-04 | 4.38 USD | 4.14 USD | +5.8% | Beat |
| 2024-08-01 | -12.83 USD | -11.63 USD | -10.3% | Miss |
Beat rate: 4/8 (50%) over reported quarters with consensus data.
VRTX valuation and analyst view
| Trailing P/E | 27.78 |
|---|---|
| Trailing EPS | 17.073 USD |
| Price / book | 6.20 |
| Dividend yield | 0.00% |
| Market cap | 119.73B |
| Analyst consensus | Buy (48 buy / 7 hold / 1 sell) |
| Avg price target | 529.64 USD |
Related research pages
Frequently asked questions
When is Vertex Pharmaceuticals (VRTX)'s next earnings date?
Vertex Pharmaceuticals is next scheduled to report on 2026-08-03, with a consensus EPS estimate of 4.74 USD and revenue estimate of 3.23B.
Did VRTX beat earnings last quarter?
In its 2026-05-04 report, VRTX posted EPS of 4.47 USD versus a 4.24 USD estimate — a beat of 5.4%.
What is VRTX's earnings track record?
Over the last 8 reported quarters with consensus data, VRTX beat estimates 4 times (50%).
What is VRTX's current P/E ratio and EPS?
VRTX trades at a trailing P/E of 27.78 on trailing EPS of 17.073199527744983 USD.
What do analysts rate VRTX?
Analyst consensus is "Buy" across 56 ratings (0 strong buy, 48 buy, 7 hold, 1 sell, 0 strong sell). Average 12-month price target: 529.64 USD.